Of @,@ patients with symptomatic aortic stenosis at high surgical risk receiving TAVR in the PARTNER ( Placement of Aortic Transcatheter Valves ) randomized trial or continued access registry , @ had both severe LV hypertrophy ( left ventricular mass index -LSB- LVMi -RSB- @ g/m ( @ ) men , @ g/m ( @ ) women ) at baseline and an LVMi measurement at @-day post-TAVR follow-up .